All Life Sciences & Technology News
Top stories summarized by our editors
8/18/2017

Monsanto secured intellectual property rights to ToolGen's CRISPR technology platform for the development of agricultural products. The agreement could help Monsanto further expand its portfolio of gene-editing tools to develop and improve sustainable crops.

Full Story:
Brownfield
More Summaries:
Monsanto, agricultural products
8/18/2017

The renewable fuel standard has helped the US economy through the reduction of both fuel prices and oil imports along with increases in tax revenues and GDP, writes Bob Dinneen, president and CEO of the Renewable Fuels Association, citing a study featured in an upcoming issue of the American Journal of Agricultural Economics. "The results that we have presented confirm that the current RFS program considerably benefits the agriculture sector," the authors of the study say.

Full Story:
The Hill
8/18/2017

To ensure the safety of baseball fans suffering from peanut allergies, Kaleo, the maker of epinephrine autoinjector Auvi-Q, has partnered with Minor League Baseball to offer peanut-free games for both this season and the coming season. The first games debuted Aug. 6 at Smith's Ballpark in Utah and First Data Field in Florida.

Full Story:
FiercePharma
More Summaries:
Kaleo
8/18/2017

Vanda launched an ad campaign highlighting akathisia, a side effect of some antipsychotic medications that causes restlessness and uncontrollable urges to move, for its schizophrenia drug Fanapt. The campaign includes two ads -- one describing akathisia symptoms and the other focused on imagery, to bring awareness to the side effect -- which clinical trial data show is less common in patients taking Fanapt.

Full Story:
FiercePharma
More Summaries:
Fanapt, Vanda
8/18/2017

A public offering of Series B convertible preferred stock and stock purchase warrants has brought in $18.1 million for EnteroMedics. The proceeds will be used to continue the company's commercialization activities, as well as to for general corporate functions and clinical and product development.

Full Story:
MassDevice (Boston)
8/18/2017

A $17.5 million all-cash agreement has been reached by Roka Bioscience to sell substantially all of its assets to newly created Institute for Environmental Health subsidiary Rokabio. The deal, which comes as Roka's first step in liquidation, requires a $2.5 million milestone payment from Roka in conformity with a license deal and provision of transition services to IEH through the end of the year.

8/18/2017

Private placements of Series B convertible preferred stock and common stock could pull in $4.3 million for DarioHealth. Plans for the proceeds from the offerings, which are expected to close by Tuesday, have not yet been disclosed by the company.

Full Story:
MassDevice (Boston)
More Summaries:
preferred stock, common stock
8/18/2017

Monroe, Conn.-based Elidah is looking to obtain up to $2 million in additional proceeds after securing up to $750,000 in pledged investment from the state-backed Connecticut Innovations venture fund last month. The company plans to use the proceeds to market its Elitone wearable device for treating women with stress urinary incontinence if it secures approval from the FDA.

8/18/2017

An Absolute Reports analysis predicts the worldwide minimally invasive spine surgery market will see a compound annual growth rate of 7.57% through 2021 because of an increasing incidence of spinal disorder. Key market players include DePuy Synthes, Stryker, Medtronic, Zimmer Biomet and NuVasive.

Full Story:
Becker's Spine Review
8/18/2017

Richard Larkin will retire as chief financial officer of Chembio Diagnostics by the end of the year. The company said it will immediately start an external search for Larkin's replacement.

Full Story:
Reuters